Finally, gene amplification was suggested as a potential mechanism driving overexpression of LRF/ZBTB7A in non-small-cell lung carcinoma, accompanied by transcriptional and post-translational aberrations [43]. Here, ZBTB7A is linked to non-small cell lung carcinoma.